Aplasia Cutis Congenita

1. Executive Overview: Understanding Aplasia Cutis Congenita

Aplasia Cutis Congenita (ACC), categorized under ICD-10 code Q82.8_3, is a rare congenital disorder characterized by the localized absence of skin at birth. While it most frequently manifests on the scalp, it can theoretically involve any area of the body. The severity of the condition ranges from small, superficial erosions that heal spontaneously to large, deep defects that expose the underlying periosteum, dura mater, or even cerebral structures.

From the perspective of reconstructive plastic surgery, ACC represents a significant clinical challenge. The primary goals of management are to prevent life-threatening complications—such as hemorrhage, infection, or sagittal sinus thrombosis—and to achieve optimal aesthetic closure of the defect. This guide provides a clinical framework for understanding the etiology, diagnostic pathways, and surgical management strategies required for the effective treatment of ACC.

2. Pathophysiology, Etiology, and Risk Factors

The exact pathogenesis of Aplasia Cutis Congenita remains heterogeneous, as it is likely a final common pathway resulting from various intrauterine insults rather than a single disease entity.

Etiological Theories

• Vascular Compromise: The most widely accepted theory suggests a focal disruption of blood supply to the skin during development. In cases of scalp ACC, this may be linked to a placental infarct or vascular accidents involving the scalp vasculature.
• Genetic Factors: While most cases are sporadic, there is evidence of autosomal dominant and recessive inheritance patterns in some syndromic forms. Mutations in the BMS1 gene have been implicated in specific subtypes.
• Teratogenic Exposure: Certain medications, specifically methimazole and carbimazole (used to treat hyperthyroidism during pregnancy), have been statistically associated with an increased incidence of ACC.
• Amniotic Band Syndrome: Mechanical constriction by amniotic bands can lead to localized ischemia and subsequent tissue necrosis in utero.

Pathophysiological Classification

The Frieden classification system is the clinical gold standard for categorizing ACC based on location, extent, and associated anomalies:

3. Signs, Symptoms, and Clinical Presentation

The clinical presentation of ACC is highly variable. In the majority of cases (approximately 70-80%), the lesion is a solitary, well-demarcated area on the vertex of the scalp.

Morphological Characteristics

• Early Presentation: At birth, the lesion may appear as a parchment-like, thin membrane, or a raw, ulcerated surface.
• Healing Phase: Smaller lesions often undergo epithelialization, leaving a hairless (alopecic) scar.
• Complications: Large or deep lesions carry significant risks, including:
  • Hemorrhage: Due to the proximity of the sagittal sinus.
  • Infection: Meningitis or cerebritis if the dura is compromised.
  • Thrombosis: Sagittal sinus thrombosis due to trauma or local inflammation.

4. Standard Diagnostic Evaluation & Workup

Diagnostic evaluation is dictated by the size, depth, and anatomical location of the lesion. A multidisciplinary approach involving neonatology, neurosurgery, and plastic surgery is essential.

Clinical Assessment

1. Physical Exam: Careful inspection of the scalp, trunk, and extremities. Look for "hair collar signs" (a ring of dark, coarse hair around the lesion), which may indicate an underlying neurodevelopmental malformation or encephalocele.
2. Neurological Screening: Evaluation for signs of increased intracranial pressure or focal neurological deficits.

Imaging Modalities

• Ultrasound (High-Frequency): The first-line imaging modality to assess the depth of the defect and the integrity of the underlying bone and dura.
• Magnetic Resonance Imaging (MRI): Indicated if there is suspicion of underlying intracranial anomalies (e.g., porencephaly, sinus thrombosis) or if the lesion is large and midline.
• Computed Tomography (CT): Used primarily to evaluate bone defects (calvarial deficiencies).

Laboratory Assays

While there is no specific blood test for ACC, patients with extensive lesions or syndromic features may require:
* Genetic Testing: Chromosomal microarray or targeted gene panels if syndromic ACC is suspected.
* Infection Markers: CBC and blood cultures if the lesion appears inflamed or purulent.

5. Therapeutic Interventions

Management strategies are tailored to the size and depth of the defect.

Conservative Management

Small, superficial defects are managed conservatively to allow for secondary intention healing.
* Topical Care: Application of silver sulfadiazine or antibiotic ointments (e.g., mupirocin) to prevent infection.
* Non-Adherent Dressings: Use of hydrocolloid or silicone-based dressings to maintain a moist wound environment and prevent trauma during dressing changes.

Surgical Interventions

Large or full-thickness defects require surgical intervention to achieve closure.
* Primary Closure: If the defect is small enough, simple excision of the defect edges followed by primary suturing may be possible.
* Tissue Expansion: The gold standard for larger scalp defects. A silicone expander is placed under the adjacent healthy scalp and gradually inflated over several weeks to create excess skin for reconstruction.
* Local Flaps: Transposition or rotation flaps are utilized when local skin laxity permits.
* Split-Thickness Skin Grafts (STSG): Reserved for cases where immediate coverage is required and other options are not viable, though this often results in a permanent hairless patch.
* Cranioplasty: If the underlying bone is absent, bone grafting or synthetic mesh reconstruction may be required once the soft tissue is stable.

6. Frequently Asked Questions (FAQ)

1. Is Aplasia Cutis Congenita a hereditary condition?
While most cases are sporadic, some subtypes are linked to genetic mutations. If multiple family members are affected, genetic counseling is recommended.

2. Does the hair grow back over the affected area?
In cases that heal via scarring, the area usually remains alopecic (hairless). Surgical reconstruction aims to restore hair-bearing skin.

3. Is ACC life-threatening?
Small lesions are generally benign. However, large defects involving the skull and dura carry risks of hemorrhage and infection, which require urgent specialist management.

4. What is the "hair collar sign"?
It is a ring of dark, long, coarse hair surrounding a scalp lesion, which often serves as a clinical marker for underlying neurodevelopmental issues.

5. How long does the healing process take?
Conservative healing of superficial lesions can take several weeks. Surgical reconstruction timelines vary based on the complexity of the flap or expansion required.

6. Can ACC be detected during pregnancy?
Yes, high-resolution fetal ultrasound can sometimes detect large scalp defects or intracranial anomalies associated with ACC in the third trimester.

7. Is there a link between thyroid medication and ACC?
Yes, maternal use of methimazole for hyperthyroidism is a known, though rare, environmental risk factor for the development of ACC in the fetus.

8. When should I see a plastic surgeon?
Immediate consultation is recommended for any scalp defect that is deep, shows signs of infection, or is associated with underlying bone or neurological abnormalities.

9. What are the long-term complications?
Potential long-term concerns include permanent alopecia, visible scarring, and, in rare cases, developmental delays if the lesion was part of a broader syndrome.

10. What is the prognosis for children with ACC?
With proper management of the wound and any associated neurological defects, the prognosis is generally excellent, and most children lead healthy, normal lives.

Disclaimer: This guide is intended for educational purposes only and does not replace professional medical advice. Always consult with a board-certified plastic surgeon or pediatric specialist for diagnosis and treatment planning.